tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Cash flow

1,885 Followers

Aquestive Therapeutics Cash Flow

AQST's free cash flow for Q4 2023 was $-4.96M. For the 2023 fiscal year, AQST's free cash flow was decreased by $4.94M and operating cash flow was $-4.94M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -6.38M$ -6.38M$ -10.46M$ -32.98M$ -45.46M$ -60.21M
Investing Cash Flow
$ -995.00K$ -995.00K$ -2.52M$ -913.00K$ -517.00K$ -663.00K
Financing Cash Flow
$ 3.97M$ 3.97M$ 12.24M$ 30.11M$ 28.46M$ 49.60M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 98.11M$ 23.87M$ 27.27M$ 28.02M$ 31.81M$ 49.33M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 4.60M$ 4.60M$ 6.44M$ 6.44M$ 8.49M$ 7.34M
Issuance Of Capital Stock
---$ 29.78M$ 6.21M$ 39.32M
Issuance Of Debt
$ -19.36M$ -19.36M$ 675.00K-$ 0.00$ 70.00M
Repayment Of Debt
$ -50.50M$ -50.50M$ 675.00K-$ -24.75M$ -52.94M
Free Cash Flow
$ -7.38M$ -7.38M$ -12.31M$ -33.89M$ -45.98M$ -60.87M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Aquestive Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis